from the United States Court of Appeals for the Federal Circuit
See other cases from the Federal Circuit.
Response Requested. (Due February 16, 2021)
Brief amicus curiae of Jonathan Stroud filed. (Distributed)
Waiver of right of respondent Novartis Pharmaceuticals Corporation to respond filed.
Petition for a writ of certiorari filed. (Response due January 7, 2021)
Argentum Pharmaceuticals LLC, Petitioner, represented by Teresa Stanek Rea
Novartis Pharmaceuticals Corporation, Respondent, represented by Mark Andrew Perry
Jonathan Stroud, Amicus Curiae, represented by Jonathan Rudolph Kominek Stroud